Global Markets Direct’s, ‘Liver Diseases Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Diseases, complete with latest updates, and special features on late-stage and discontinued projects. […]
Pharmaceuticals
Subscribe
House Dust Mite Allergy – Pipeline Review, H2 2013
Global Markets Direct’s, ‘House Dust Mite Allergy Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for House Dust Mite Allergy, complete with latest updates, and special features on […]
Enterobacteriaceae Infections – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Enterobacteriaceae Infections Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Enterobacteriaceae Infections, complete with latest updates, and special features on late-stage and discontinued projects. […]
Inflammatory Bowel Disease – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Inflammatory Bowel Disease Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Inflammatory Bowel Disease, complete with latest updates, and special features on late-stage and […]
T-Cell Lymphomas – Pipeline Review, H2 2013
Global Markets Direct’s, ‘T-Cell Lymphomas Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for T-Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. […]
Secondary Hyperparathyroidism – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Secondary Hyperparathyroidism Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Secondary Hyperparathyroidism, complete with latest updates, and special features on late-stage and discontinued projects. […]
Influenza A And B Infections – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Influenza A And B Infections – Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Influenza A And B Infections, complete with latest updates, and […]
Gram-Positive Bacterial Infections – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Gram-Positive Bacterial Infections Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Gram-Positive Bacterial Infections, complete with latest updates, and special features on late-stage and […]
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, […]
Rheumatoid Arthritis Pain – Pipeline Review, H2 2013
Global Markets Direct’s, ‘Rheumatoid Arthritis Pain Pipeline Review, H2 2013’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Rheumatoid Arthritis Pain, complete with latest updates, and special features on late-stage and […]